Inherited lipodystrophies and the metabolic syndrome

Clinical Endocrinology

Volumn 67, Issue 4, 2007, Pages 479-484

  Monajemi, Houshang ^a,c   Stroes, Erik ^a   Hegele, Robert A ^b   Fliers, Eric ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN;

ACANTHOSIS NIGRICANS; ADIPOSE TISSUE; BODY FAT DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONGENITAL DISORDER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FACE DYSMORPHIA; FAMILIAL DISEASE; FATTY LIVER; HIRSUTISM; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPODYSTROPHY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PREVALENCE; PRIORITY JOURNAL; PROGERIA; REVIEW; SEX DIFFERENCE; TISSUE TRANSPLANTATION;

BODY COMPOSITION; FEMALE; HUMANS; LIPODYSTROPHY; MALE; METABOLIC SYNDROME X; SUBCUTANEOUS FAT;

EID: 34548688187     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02906.x     Document Type: Review

References (42)

1. Berardinelli, W. (1954) An undiagnosed endocrinometabolic syndrome: report of 2 cases. Journal of Clinical Endocrinology and Metabolism, 14, 193 204.
2. Garg, A. (2004) Acquired and inherited lipodystrophies. New England Journal of Medicine, 350, 1220 1234.
3. Seip, M. Trygstad, O. (1963) Generalized lipodystrophy. Archives of Disease in Childhood, 38, 447 453.
4. Garg, A. (2004) Acquired and inherited lipodystrophies. New England Journal of Medicine, 350, 1220 1234.
5. Agarwal, A.K. Garg, A. (2006) Genetic disorders of adipose tissue development, differentiation, and death. Annual Review of Genomics and Human Genetics, 7, 175 199.
6. Garg, A., Wilson, R., Barnes, R., Arioglu, E., Zaidi, Z., Gurakan, F., Kocak, N., O'Rahilly, S., Taylor, S.I., Patel, S.B. Bowcock, A.M. (1999) A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. Journal of Clinical Endocrinology and Metabolism, 84, 3390 3394.
7. Agarwal, A.K., De Arioglu, E.A.S., Akkoc, N., Taylor, S.I., Bowcock, A.M., Barnes, R.I. Garg, A. (2002) AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nature Genetics, 31, 21 23.
8. Agarwal, A.K., Barnes, R.I. Garg, A. (2004) Genetic basis of congenital generalized lipodystrophy. International Journal of Obesity and Related Metabolic Disorders, 28, 336 339.
9. Magre, J., Delepine, M., Khallouf, E., Gedde-Dahl, T. Jr., Van M.L., Sobel, E., Papp, J., Meier, M., Megarbane, A., Bachy, A., Verloes, A., d'Abronzo, F.H., Seemanova, E., Assan, R., Baudic, N., Bourut, C., Czernichow, P., Huet, F., de Grigorescu, F.K.M., Lacombe, D., Labrune, P., Lanza, M., Loret, H., Matsuda, F., Navarro, J., Nivelon-Chevalier, A., Polak, M., Robert, J.J., Tric, P., Tubiana-Rufi, N., Vigouroux, C., Weissenbach, J., Savasta, S., Maassen, J.A., Trygstad, O., Bogalho, P., Freitas, P., Medina, J.L., Bonnicci, F., Joffe, B.I., Loyson, G., Panz, V.R., Raal, F.J., O'Rahilly, S., Stephenson, T., Kahn, C.R., Lathrop, M. Capeau, J. (2001) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nature Genetics, 28, 365 370.
10. Agarwal, A.K., Simha, V., Oral, E.A., Moran, S.A., Gorden, P., O'Rahilly, S., Zaidi, Z., Gurakan, F., Arslanian, S.A., Klar, A., Ricker, A., White, N.H., Bindl, L., Herbst, K., Kennel, K., Patel, S.B., Al-Gazali, L. Garg, A. (2003) Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. Journal of Clinical Endocrinology and Metabolism, 88, 4840 4847.
11. Fu, M., Kazlauskaite, R., Baracho, M.F., Santos, M.G., Brandao-Neto, J., Villares, S., Celi, F.S., Wajchenberg, B.L. Shuldiner, A.R. (2004) Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects. Journal of Clinical Endocrinology and Metabolism, 89, 2916 2922.
12. Young, L.W., Radebaugh, J.F., Rubin, P., Sensenbrenner, J.A., Fiorelli, G. Mckusick, V.A. (1971) New syndrome manifested by mandibular hypoplasia, acroosteolysis, stiff joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys. Birth Defects Original Article Series, 7, 291 297.
13. Simha, V. Garg, A. (2002) Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia. Journal of Clinical Endocrinology and Metabolism, 87, 776 785.
14. Agarwal, A.K., Fryns, J.P., Auchus, R.J. Garg, A. (2003) Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Human Molecular Genetics, 12, 1995 2001.
15. Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D'Apice, M.R., Massart, C., Capon, F., Sbraccia, P., Federici, M., Lauro, R., Tudisco, C., Pallotta, R., Scarano, G., Dallapiccola, B., Merlini, L. Bonne, G. (2002) Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. American Journal of Human Genetics, 71, 426 431.
16. Capell, B.C. Collins, F.S. (2006) Human laminopathies: nuclei gone genetically awry. Nature Reviews Genetics, 7, 940 952.
17. Hegele, R. (2005) LMNA mutation position predicts organ system involvement in laminopathies. Clinical Genetics, 68, 31 34.
18. Pollex, R.L. Hegele, R.A. (2004) Hutchinson-Gilford progeria syndrome. Clinical Genetics, 66, 375 381.
19. Eriksson, M., Brown, W.T., Gordon, L.B., Glynn, M.W., Singer, J., Scott, L., Erdos, M.R., Robbins, C.M., Moses, T.Y., Berglund, P., Dutra, A., Pak, E., Durkin, S., Csoka, A.B., Boehnke, M., Glover, T.W. Collins, F.S. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature, 423, 293 298.
20. Rautenstrauch, T. Snigula, F. (1977) Progeria: a cell culture study and clinical report of familial incidence. European Journal of Pediatrics, 124, 101 111.
21. Pivnick, E.K., Angle, B., Kaufman, R.A., Hall, B.D., Pitukcheewanont, P., Hersh, J.H., Fowlkes, J.L., Sanders, L.P., O'Brien, J.M., Carroll, G.S., Gunther, W.M., Morrow, H.G., Burghen, G.A. Ward, J.C. (2000) Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review. American Journal of Medical Genetics, 90, 131 140.
22. Dunnigan, M.G., Cochrane, M.A., Kelly, A. Scott, J.W. (1974) Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Quarterly Journal of Medicine, 43, 33 48.
23. Kobberling, J., Willms, B., Kattermann, R. Creutzfeldt, W. (1975) Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik, 29, 111 120.
24. Kobberling, J. Dunnigan, M.G. (1986) Familial partial lipodystrophy: two types of an X-linked dominant syndrome, lethal in the hemizygous state. Journal of Medical Genetics, 23, 120 127.
25. Herbst, K.L., Tannock, L.R., Deeb, S.S., Purnell, J.Q., Brunzell, J.D. Chait, A. (2003) Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care, 26, 1819 1824.
26. Jackson, S.N., Howlett, T.A., Mcnally, P.G., O'Rahilly, S. Trembath, R.C. (1997) Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. QJM, 90, 27 36.
27. Morel, C.F., Thomas, M.A., Cao, H., O'Neil, C.H., Pickering, J.G., Foulkes, W.D. Hegele, R.A. (2006) A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2. Journal of Clinical Endocrinology and Metabolism, 91, 2689 2695.
28. Peters, J.M., Barnes, R., Bennett, L., Gitomer, W.M., Bowcock, A.M. Garg, A. (1998) Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nature Genetics, 18, 292 295.
29. Cao, H. Hegele, R.A. (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Human Molecular Genetics, 9, 109 112.
30. Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., Williams, T.D., Lewis, H., Schafer, A.J., Chatterjee, V.K. O'Rahilly, S. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 402, 880 883.
31. Agarwal, A.K. Garg, A. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. Journal of Clinical Endocrinology and Metabolism, 87, 408 411.
32. Hegele, R.A., Cao, H., Frankowski, C., Mathews, S.T. Leff, T. (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes, 51, 3586 3590.
33. Savage, D.B., Tan, G.D., Acerini, C.L., Jebb, S.A., Agostini, M., Gurnell, M., Williams, R.L., Umpleby, A.M., Thomas, E.L., Bell, J.D., Dixon, A.K., Dunne, F., Boiani, R., Cinti, S., Vidal-Puig, A., Karpe, F., Chatterjee, V.K. O'Rahilly, S. (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes, 52, 910 917.
34. Monajemi, H., Zhang, L., Li, G., Jeninga, E.H., Cao, H., Maas, M., Brouwer, C.B., Kalkhoven, E., Stroes, E., Hegele, R.A. Leff, T. (2007) Familial partial lipodystrophy phenotype resulting from a single-base mutation in DNA binding domain of peroxisome proliferator-activated receptor gamma. Journal of Clinical Endocrinology and Metabolism, 92, 1606 1612.
35. Al-Attar, S.A., Pollex, R.L., Robinson, J.F., Miskie, B.A., Walcarius, R., Rutt, B.K. Hegele, R.A. (2006) Semi-automated segmentation and quantification of adipose tissue in calf and thigh by MRI: a preliminary study in patients with monogenic metabolic syndrome. BMC Medical Imaging, 6, 11.
36. George, S., Rochford, J.J., Wolfrum, C., Gray, S.L., Schinner, S., Wilson, J.C., Soos, M.A., Murgatroyd, P.R., Williams, R.M., Acerini, C.L., Dunger, D.B., Barford, D., Umpleby, A.M., Wareham, N.J., Davies, H.A., Schafer, A.J., Stoffel, M., O'Rahilly, S. Barroso, I. (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science, 304, 1325 1328.
37. Garofalo, R.S., Orena, S.J., Rafidi, K., Torchia, A.J., Stock, J.L., Hildebrandt, A.L., Coskran, T., Black, S.C., Brees, D.J., Wicks, J.R., Mcneish, J.D. Coleman, K.G. (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. Journal of Clinical Investigations, 112, 197 208.
38. Tan, K., Kimber, W.A., Luan, J., Soos, M.A., Semple, R.K., Wareham, N.J., O'Rahilly, S. Barroso, I. (2007) Analysis of genetic variation in Akt2/PKB-beta in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes. Diabetes, 56, 714 719.
39. Javor, E.D., Cochran, E.K., Musso, C., Young, J.R., Depaoli, A.M. Gorden, P. (2005) Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes, 54, 1994 2002.
40. Oral, E.A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A.J., Depaoli, A.M., Reitman, M.L., Taylor, S.I., Gorden, P. Garg, A. (2002) Leptin-replacement therapy for lipodystrophy. New England Journal of Medicine, 346, 570 578.
41. Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J.K., Shulman, G.I., Castle, A.L., Vinson, C., Eckhaus, M. Reitman, M.L. (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. Journal of Clinical Investigations, 105, 271 278.
42. Klebanov, S., Astle, C.M., Desimone, O., Ablamunits, V. Harrison, D.E. (2005) Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility. Journal of Endocrinology, 186, 203 211.